Viewing Study NCT06589258


Ignite Creation Date: 2025-12-25 @ 12:07 AM
Ignite Modification Date: 2026-02-24 @ 5:51 AM
Study NCT ID: NCT06589258
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-17
First Post: 2024-09-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cannabidiol Into Breastmilk
Sponsor: Centre Hospitalier Régional d'Orléans
Organization:

Study Overview

Official Title: Study of the Passage of (CBD) Into Breast Milk and Its Biological Impact on Breast-fed Children
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CBD-ALLT
Brief Summary: Really few data published to date on the passage of CBD into breast milk. The investigators known that 17.5 percent of the French human being between 18 and 34 years old consume CBD and among this, nearly half are women. None official French data to say how many French breastfeeding mothers consume CBD. CBD is a legal, psychoactive but not psychoaddictive substance. CBD's pharmacokinetic and pharmacodynamics make us fear that CBD could easily go through mother's milk. No published data available on possible effect in breast-fed child, not even on possible biological passage in breast-fed child. The aim of his study is to evaluate the passage of CBD in blood and milk at different moments of the breastfeeding (mothers) and its possible found in the infants'urine.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: